These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 28666474

  • 1. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
    Su T, Jin Q, Liu Z.
    BMC Nephrol; 2017 Jun 30; 18(1):208. PubMed ID: 28666474
    [Abstract] [Full Text] [Related]

  • 2. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S, Canivet E, Wuillai A, Maheut H, Randoux C, Bonnet JM, Renaux JL, Chanard J.
    Nephrol Dial Transplant; 2003 Oct 30; 18(10):2097-104. PubMed ID: 13679486
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
    Evenepoel P, Dejagere T, Verhamme P, Claes K, Kuypers D, Bammens B, Vanrenterghem Y.
    Am J Kidney Dis; 2007 May 30; 49(5):642-9. PubMed ID: 17472846
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD.
    Crit Care Med; 1999 Oct 30; 27(10):2224-8. PubMed ID: 10548211
    [Abstract] [Full Text] [Related]

  • 8. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
    Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I.
    Pharmacotherapy; 2010 Nov 30; 30(11):1117-26. PubMed ID: 20973685
    [Abstract] [Full Text] [Related]

  • 9. Involvement of ionic interactions in cytokine adsorption of polyethyleneimine-coated polyacrylonitrile and polymethyl methacrylate membranes in vitro.
    Moriyama K, Kato Y, Hasegawa D, Kurimoto Y, Kawaji T, Nakamura T, Kuriyama N, Shimomura Y, Nishida O.
    J Artif Organs; 2020 Sep 30; 23(3):240-246. PubMed ID: 32394409
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J, Lavaud S, Maheut H, Kazes I, Vitry F, Rieu P.
    Nephrol Dial Transplant; 2008 Jun 30; 23(6):2003-9. PubMed ID: 18156457
    [Abstract] [Full Text] [Related]

  • 12. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia.
    Tang IY, Cox DS, Patel K, Reddy BV, Nahlik L, Trevino S, Murray PT.
    Ann Pharmacother; 2005 Feb 30; 39(2):231-6. PubMed ID: 15632219
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z, Ni H, Lu B.
    ASAIO J; 2012 Feb 30; 58(1):46-50. PubMed ID: 22210650
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration.
    Kozek-Langenecker SA, Kettner SC, Oismueller C, Gonano C, Speiser W, Zimpfer M.
    Crit Care Med; 1998 Jul 30; 26(7):1208-12. PubMed ID: 9671370
    [Abstract] [Full Text] [Related]

  • 16. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Jul 30; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study.
    François K, Wissing KM, Jacobs R, Boone D, Jacobs K, Tielemans C.
    BMC Nephrol; 2014 Jul 03; 15():104. PubMed ID: 24993584
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.